NexImmune (NEXI) Insider Trading & Ownership Add Compare Share Share Insider Trades Stock AnalysisChartCompetitorsEarningsInsider TradesSEC FilingsShort InterestTrendsBuy This Stock NexImmune (NASDAQ:NEXI) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage14.90%Number OfInsiders Buying(Last 3 Years)2Amount OfInsider Buying(Last 3 Years)$224.00KNumber OfInsiders Selling(Last 3 Years)1Amount OfInsider Selling(Last 3 Years)$8.28K Get NEXI Insider Trade Alerts Want to know when executives and insiders are buying or selling NexImmune stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address NEXI Insider Buying and Selling by Quarter NexImmune Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails6/11/2024Kristi JonesCEOBuy1$0.01$0.01 11/21/2023Alan S RoemerDirectorSell3,833$2.16$8,279.28 3/30/2023Sol J BarerDirectorBuy16,000$10.25$164,000.00 11/16/2022Sol J BarerDirectorBuy5,000$12.00$60,000.00 (Data available from 1/1/2013 forward) NEXI Insider Trading Activity - Frequently Asked Questions Who is on NexImmune's Insider Roster? The list of insiders at NexImmune includes Alan S Roemer, Kristi Jones, and Sol J Barer. Learn more on insiders at NEXI. What percentage of NexImmune stock is owned by insiders? 14.90% of NexImmune stock is owned by insiders. Learn more on NEXI's insider holdings. Which NexImmune insiders have been buying company stock? The following insider purchased NEXI shares in the last 24 months: Kristi Jones ($0.01). How much insider buying is happening at NexImmune? Insiders have purchased a total of 1 NEXI shares in the last 24 months for a total of $0.01 bought. Which NexImmune insiders have been selling company stock? The following insider sold NEXI shares in the last 24 months: Alan S Roemer ($8,279.28). How much insider selling is happening at NexImmune? Insiders have sold a total of 3,833 NexImmune shares in the last 24 months for a total of $8,279.28 sold. More Insider Trading Tools from MarketBeat Related Companies Ampio Pharmaceuticals Insider Trading biote Insider Trading Calithera Biosciences Insider Trading Clever Leaves Insider Trading Clever Leaves Insider Trading Cocrystal Pharma Insider Trading Fortress Biotech Insider Trading Neonc Technologies Insider Trading Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insider Selling Hits Market Leaders—Should You Be Worried?3 Small Caps Drawing Insider and Institutional SupportDo They Know Something? Insiders & Congress Buy UnitedHealthMicron Insiders Sell But Investors Should Buy, Buy, BuySizzling Insider Buys for Your High-Yield Watchlist This page (NASDAQ:NEXI) was last updated on 7/16/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredTrump’s biggest move, misreportedThe media and financial pundits are all misreading Trump’s actions. They think Trump wants to make Canada t...Porter & Company | SponsoredIs this secretive Asian company trying to take over Bitcoin?A mysterious Asian conglomerate is buying billions in Bitcoin — but one legendary trader says that’s the wrong...Brownstone Research | SponsoredNvidia’s next AI move could catch traders flat-footedTired of Missing Big AI Moves Like Nvidia? You’re not the problem—your trading system is. Tim’s XGPT system...Timothy Sykes | SponsoredTrump has to finance $21 trillion. Here’s His Move…Trump needs $21 trillion to fund his agenda — and insiders believe he’s quietly preparing a major shift in the...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NexImmune, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share NexImmune With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free NEXI Stock Alerts